Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
Leucotriene antagonists: A new class of antiasthmatic drugs
Pneumon 1999;12(2):123-132
ABSTRACT
SUMMARY Leukotriene antagonists are a newly introduced class of drugs for the treatment of asthma. Studies that have been published so far show that leukotriene antagonists have mild anti-inflammatory and bronchodilating effect and are particularly effective in treating Aspirin and Exercise induced asthma. In the 1997 ATS and the 1998 GINA Guidelines, Leukotriene antagonists are included and their use is suggested for the treatment of mild and moderate asthma. Pneumon 1999, 12 (2): 123-132
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
